Last reviewed · How we verify
Intravenous GR270773- Phospholipid Emulsion
At a glance
| Generic name | Intravenous GR270773- Phospholipid Emulsion |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study To Compare The Effects Of The Infusion Of A Sepsis Drug Between Healthy Adults And Adults With Damaged Livers (PHASE1)
- GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |